Search

Wednesday 26 June 2024

Arovella Therapeutics has successfully manufactured and passed quality release testing

Arovella Therapeutics (ASX:ALA) has successfully manufactured and passed quality release testing for its lead product ALA-101 | ASX Announcement: https://announcements.asx.com.au/asxpdf/20240102/pdf/05z33l2t26k412.pdf #ALA #Cancer

Free stock updates

Subscribe to receive the latest stock news, CEO interviews, expert insights, events and offers directly into your inbox